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Summary
Blood supply to the brain is secured by an extensive collat-
eral circulation system, which can be divided into primary
routes, i.e., the Circle of Willis, and secondary routes, e.g.,
collaterals from the external to the internal carotid artery
and leptomeningeal collaterals. Collateral flow is the basis
for acute stroke treatment, since neurones will only sur-
vive long enough to be rescued with reperfusion therapies
if there is sufficient collateral flow. Poor collateral flow is
associated with worse outcome and faster growth of larger
infarcts in acute stroke treatment. Therapeutic promotion
of collateral flow theoretically offers the chance for out-
come improvement, but randomised trials are lacking. The
extent of collateral flow is highly variable between individ-
uals. As a consequence, the speeds of infarct growth are
highly variable, resulting in varying individual treatment
time windows until the whole salvageable tissue has be-
come infarcted. An ideal patient selection for reperfusion
therapies should be based on imaging of the salvageable
tissue, the so called penumbra. The penumbra can be
approximately visualised by computed tomography (CT)
and magnetic resonance imaging (MRI), but both methods
are significantly inaccurate in about 25% of the patients.
There is a need for improved penumbra imaging by CT
and MRI, and first studies applying machine learning tech-
niques have shown promising results.
Key words: acute stroke, treatment, anaemia, haemoglo-
bin decrease, infarct growth, haemodilution
The cerebral collateral system
Collateral blood circulation is common in most species as a
system of vascular redundancy designed to preserve blood
supply in the event of failure of the primary blood supply-
ing system. In humans, collateral circulation can be found
in most organs, and the blood supply to the brain especial-
ly is secured by an extensive collateral circulation system.
The collateral circuits to the brain can be divided into pri-
mary and secondary routes. The primary route consists of
the Circle of Willis, which mainly links the anterior with
the posterior circulation and the nearby main cerebral ar-
teries to each other (fig. 1). The secondary routes include
all external to internal carotid artery connections through
facial, maxillary, middle meningeal, and occipital arteries.
The most common one is the connection through the oph-
thalmic artery: retrograde blood flow via the ophthalmic
artery allows supply from the external carotid artery to the
internal carotid artery (ICA) in the case of proximal occlu-
sion of the ICA. In addition, the secondary routes comprise
leptomeningeal collaterals, perforator collaterals, the tectal
plexus and the ophthalmic plexus. Leptomeningeal collat-
erals are small pial arterioles connecting the territories of
the middle cerebral artery (MCA) with those of the anteri-
or (ACA) and posterior cerebral artery (PCA) (fig. 2). Lep-
tomeningeal collaterals are very important in occlusions
of the intracranial arteries. Perforator collaterals connect
lenticulostriate and thalamostriate arteries with branches of
the MCA and PCA and can be recruited in addition to lep-
tomeningeal collaterals in MCA occlusions.
The extent of collaterals is highly variable between indi-
viduals, but there is also intraindividual variability during
the lifetime: rarefaction of the collaterals is observed with
aging and as a result of vascular risk factors [1].
The role of collaterals in acute ischaemic
stroke
Intravenous thrombolysis (IVT) and endovascular treat-
ment (EVT) have been proven to have considerable thera-
peutic effect in acute ischaemic stroke in several large clin-
ical trials [2–10]. The treatment effect of these reperfusion
therapies is based on the penumbral concept, which as-
sumes the existence of salvageable tissue due to gradual in-
farct growth within the territory of the occluded vessel (fig.
3) [11, 12]. Theoretical considerations quantify this grad-
ual infarct growth to be 1.9 million neurones dying every
minute in occlusion of one of the large arteries [13]. This
is fast – but why do neurones not die all at once after a few
minutes, given results from in-vitro experiments that have
shown that neuronal cell death occurs already minutes after
interruption of energy supply? Neuronal cell death can
only be delayed by ongoing energy supply – that is, the
whole penumbral concept as well as the therapeutic effect
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of reperfusion therapies relies on collateral blood flow. De-
pending on the extent of collateral blood flow, neuronal
death can be delayed in a variable manner or even prevent-
ed. The extent of collateral flow is highly variable between
individuals, but it is usually greatest in the case of occlu-
sion of the extracranial vessels: almost 60% of patients tol-
erate even complete ICA occlusion without infarct devel-
opment because of sufficient blood supply through primary
and secondary collateral circuits [14, 15]. The recruitment
of inactive, vasoconstricted collaterals can take place ex-
tremely fast: it takes only 12 seconds after ICA occlusion
in rats until maximal dilatation of the leptomeningeal col-
laterals [16].
The extent of collateral flow has major impact on the out-
come of conservatively treated patients and of patients
treated with IVT or EVT. Even at hospital admission, the
severity of neurological deficits already depends on the ex-
tent of collaterals [17, 18], which is revealed by variable
infarct sizes in baseline imaging, depending on the collat-
eral quality [19, 20]. Several studies demonstrated that the
Figure 1: Intracranial vessels. Yellow: Circle of Willis (adapted from the Stroke Guidelines of the University Hospital of Bern 2017, www.stroke-
center.ch).
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outcome after IVT and EVT is also highly dependent on
the extent of collateral flow [21–33]: not only the volume
of the final infarct [19, 20, 24, 34–38], but also the success
of reperfusion [20, 27, 39, 40] are influenced by the collat-
eral quality. In addition, the risk for symptomatic bleeding
after reperfusion therapy seems to rise with poor collateral
flow [30, 41, 42].
Implications of the collateral variability on
time windows for acute stroke treatment
Reperfusion therapy by means of IVT and EVT is highly
effective. In large randomised trials only 5–14 patients had
to be treated with IVT and 3–7 patients with EVT to pre-
vent one patient from death or dependency [2–10]. The
therapeutic effect of these therapies is not only dependent
on the success of reperfusion, but is also highly time de-
pendent. Treatment time windows of 4.5 hours for IVT and
7.3 hours for EVT have been defined by pooled analysis
of the patients treated in the large trials [43, 44]. Although
patients on average may not benefit from later therapy, pa-
tient selection based on these time windows would neglect
the large interindividual variability of the extent of collat-
eral flow. This regimen would lead to the exclusion from
therapy of many patients who would, in fact, benefit. In-
deed, infarct growth is much less dependent on the elapsed
time than on the quality of collaterals: good collaterals
slow down infarct growth and poor collaterals accelerate
it [19, 45–48]. Of course reperfusion treatment should al-
ways be initiated as early as possible because “time is
brain”, but the collaterals set the pace of neuronal loss,
and with this the individual time window until infarction of
all tissue at risk. Figure 4 illustrates two patients in whom
the approximated velocity of neuronal cell loss differed be-
tween 9000 neurones/min and more than 460 billion neu-
rones/min. This large variability of the velocity of neuronal
cell loss implies that there are probably many patients el-
igible for therapy far beyond time windows that were cal-
culated on the average of patients. Patient selection based
Figure 2: Leptomeningeal collateral flow in occlusion of the proximal middle cerebral artery as seen in conventional angiography (sagittal
plane). (A1–A3): serial images after contrast agent application into the internal carotid artery showing proximal middle cerebral artery occlu-
sion (red arrow in A1) with subsequent filling of leptomeningeal collaterals 2.5 sec thereafter fed by the anterior (above and right of blue line in
A2) and posterior circulation. After 5.3 sec retrograde collateral flow filled the superior (red dots) and inferior branch (green dots) of the occlud-
ed middle cerebral artery (A3 + A3 zoomed). (B) After windowing A3 capillary filling visualised supply of the whole middle cerebral artery terri-
tory by collaterals. (C) The same branches filled retrogradely by collaterals in A3 are filled anterogradely after reperfusion of the occlusion.
(Pictures: Stroke Centre Bern)
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on restricted time windows would not only exclude from
therapy eligible patients outside the time windows, but also
all patients with wake-up stroke and with unknown symp-
tom onset, who account for at least one third of all stroke
patients. Therefore, patient selection for reperfusion thera-
py should be individualised by imaging salvageable tissue,
rather than being restricted by strict time windows.
That imaging-based patient selection is a promising con-
cept has recently been demonstrated by the DAWN trial
(not yet published), which included patients with large
artery occlusion between 6 and 24 hours after symptom
onset for EVT, if they presented with a so called clinical-
image mismatch: patients had to be clinically severely af-
fected (NIHSS ≥10) but infarct core had to be restricted
Figure 3: Illustration of the penumbra concept. Infarct core (red): infarcted tissue. Penumbra (orange): salvageable tissue at risk for infarction
in case of persistence vessel occlusion. Oligaemia (yellow): hypoperfused tissue without risk for infarction. Cerebral blood flow decreases in
direction to the infarct core. Decreased blood flow can be compensated by an increased oxygen extraction fraction and vasodilation of collater-
al vessels sufficiently enough in the oligaemia but not in the penumbra. (Picture: Stroke Centre Bern)
Figure 4: Variable velocities of infarct growth. Patient A: carotid T occlusion and fetal type posterior cerebral artery, 2 hours after symptom on-
set hyperintensity of the whole hemisphere in diffusion-weighted imaging (DWI) with corresponding hypodensity in CT perfusion (CBV). Pa-
tient B: persistent carotid occlusion, slow infarct growth in DWI over 17 days. Neuronal cell loss was estimated based on volumetric measure-
ment of the lesion and the average neuronal density described in Saver et al. [13] (Pictures: Stroke Centre Bern)
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(<21 cc if patients was ≥80 years, <31 cc if patients was
<80 years and NIHSS ≥10 or <51 cc if patient was <80
years and NIHSS ≥20). The trial revealed a clear effect of
reperfusion therapy in these selected patients: the number
needed to treat was reported to be 2.8 for 90-day functional
independence. Future trials will hopefully allow the inclu-
sion of even more patients by a more detailed visualisation
of salvageable tissue.
Assessment of cerebral collaterals and salvage-
able tissue
Collaterals can be visualised most accurately by use of
conventional angiography, which is the gold standard due
to its high temporal and spatial resolution [49–51]. Unfor-
tunately, there are several systems for grading collateral
flow, which hampers the comparability of study results.
One of the scoring systems most often used is the one
described by the Society of NeuroInterventional Surgery
(formally ASITN/SIR) [52]. In clinical practice, therapeu-
tic decisions are usually made in advance of conventional
angiography, on the basis of noninvasive imaging with
magnetic resonance (MR) or computed tomography (CT).
Although grading of collaterals is also possible by CT and
MR imaging, it is less accurate [53, 54]. Furthermore, there
is more a need for an accurate visualisation of salvageable
tissue at risk for infarction, rather than pure information on
collateral flow.
Positron emission tomography (PET) is the gold standard
for imaging of the penumbra because it allows the most
accurate visualisation of the infarct core and the hypop-
erfused tissue [55]. A cerebral blood flow (CBF) below
12 ml/100g/min defines the area of infarct core, a flow of
12–22 ml/100g/min identifies the tissue at risk for infarc-
tion in the case of persistence vessel occlusion, and a flow
greater than 22 ml/100g/min defines an area of oligaemia,
i.e., hypoperfused tissue without risk for infarction [56].
Although very accurate, PET imaging is not a practica-
ble technique in the acute setting of stroke. Both MR and
CT allow approximation of the penumbra, but show a rele-
vant inaccuracy of the imaging techniques used up to now
[56–58]. The core is defined with MR imaging of the le-
sion in diffusion-weighted imaging (DWI) and the hypop-
erfused area by perfusion imaging. With CT, the core is vi-
sualised by means of cerebral blood volume (CBV) and the
hypoperfused area by perfusion imaging. Visualisation of
the infarct core with MRI is more accurate than with CT,
but diffusion lesion reversal can occur because the DWI le-
sion may overestimate the infarct core and contain up to
25% false positive, surviving, tissue [59]. Definition of the
core by use of quantitative analysis of the calculated Ap-
parent Diffusion Coefficient (ADC) maps is more accurate
[59].
Imaging of the hypoperfused tissue at risk by use of MR
and CT perfusion imaging relies on surrogates of perfusion
parameters calculated from nondeconvolved (e.g, time to
peak TTP]) or deconvolved (e.g. CBF, mean transit time
[MTT], time to maximum [Tmax]) tissue residue function
(time contrast curve) of the intravascular contrast bolus
[56]. Different maps computed from MR and CT imaging
have been developed and compared with PET measure-
ments. Recent studies indicate that Tmax thresholds of
>6 sec improves the prediction of salvageable tissue com-
pared with previous maps [60]. Nevertheless, estimation
of the tissue at risk based on maps derived from simple
thresholding is prone to errors in about 25% of patients,
with variations of the predicted penumbra of up to 100 ml
[61]. In most cases the penumbra is overestimated owing
to inclusion of parts of the oligaemia. Newer studies ap-
plying machine learning techniques instead of using only
the somewhat arbitrary thresholds of surrogate parameters
have shown first promising results with improved accura-
cy of the penumbra imaging [62].
Potential treatment options for improving col-
lateral flow
Given the association of poor collateral flow with poor out-
come, and larger and faster infarct growth, therapeutic pro-
motion of collateral flow may offer the chance to improve
outcome beyond efforts to raise reperfusion success rates
and to minimise treatment delay. Up to now, mainly in-vivo
data support the potential benefit from promoting collat-
eral flow [63, 64]. Possible treatment options include in-
duced hypertension (e.g. by phenylephrine), selective cere-
bral vasodilation (e.g., by nitric oxide or sphenopalatine
ganglion stimulation), external counterpulsation, and en-
dovascular partial occlusion of the abdominal aorta [63,
64]. On the one hand, induced hypertension and partial oc-
clusion of the abdominal aorta aim to improve collateral
circulation by raising the perfusion pressure through an in-
creased systemic pressure and flow diversion, respectively.
External counterpulsation aims also to raise the perfusion
pressure of collaterals, but through augmented diastolic
flow. On the other hand, selective cerebral vasodilatation
aims to increase collateral flow by reducing the vessel re-
sistance within collateral arterioles.
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